Intrexon | XON - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Agenus USD 35M 32M 2026-03
Alaunos Therapeutics USD 354K 1.03M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Heron Therapeutics USD 26.12M 2.53M 2026-03
Incyte USD 4.02B 435.22M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
MacroGenics USD 66.52M 9.3M 2026-03
MannKind USD 52.83M 22.05M 2026-03
Merck USD 5.33B 9.24B 2026-03
Novartis USD 6.88B 4.56B 2026-03
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veracyte USD 263.14M 99.44M 2026-03
Xencor USD 14.17M 39.9M 2026-03